Navigation Links
Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
Date:1/12/2009

Network recommend the use of Oncotype DX for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive. For more information about Oncotype DX, please visit http://www.oncotypedx.com.

About Genomic Health

Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(R), which has been shown to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's expectation regarding the timing of reporting results of the validation study, the company's belief that the initiation of the clinical validation study brings it closer to delivering a tool that may lead to more targeted approaches to treating stage II colon cancer, and the potential utility, attributes or impact of a predictive or prognostic test for stage II colon cancer. These risks and uncertainties include, but are not limited to: the results of the clinical validation study; delays or difficulties in completion of the clinical validation study; the applicability of clinical study res
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
2. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
3. AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
4. Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
5. Transgenomic Receives Accreditation From College of American Pathologists
6. Genomic Health Announces Appointment of Ginger Graham to Board of Directors
7. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
8. Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium
9. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
10. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
11. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 1000 balances ... takes input on customers’ weighing needs and expertly narrows ... shortlist of balances, scales or even terminals. , ... and smallest weight (or select readability instead) and define ... few additional selection criteria narrows down the list to ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 ... http://www.draperuniversity.com , is proud to announce that for ... 17 different countries will converge on the Draper ... for an intensive, experiential program focused on entrepreneurship, ... highly selective school, currently running its sixth cohort, ...
(Date:7/24/2014)...   Cypher Genomics, Inc., the genome ... Adam Simpson as president and chief operating ... annotation and interpretation of individual human genomes for ... technology has the potential to play a transformative ... optimizing therapeutic approaches and reducing adverse drug reactions," ...
Breaking Biology Technology:Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3
... Calif., Sept. 27 Poniard,Pharmaceuticals, Inc. (Nasdaq: ... announced that the Company,s common shares are now,eligible ... and will begin trading,there under the same symbol ... for listing on the NASDAQ Global Market represents ...
... 454 Life Sciences, a Roche,company, in collaboration with ... a method, using the company,s Genome Sequencer(TM),FLX system, ... level of detail. The new method enables researchers ... to the,genetic code in a very fast and ...
... strategic plan, WATERTOWN, Mass., Sept. 27 ... Biomedical Research Institute, an independent,not-for- profit biomedical research ... scientists, a 23% increase in its scientific staff. ... fruits of a three-year,strategic planning process designed to ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market 2454 Sequencing(TM): Science Paper Suggests That Structural Variation Plays an Important Role in Genetic Variation 2454 Sequencing(TM): Science Paper Suggests That Structural Variation Plays an Important Role in Genetic Variation 3New Scientists Boost Disease-based Research at Boston Biomedical Research Institute 2New Scientists Boost Disease-based Research at Boston Biomedical Research Institute 3
(Date:7/25/2014)... research at the University of Adelaide has opened the way ... to powdery mildew. , In Australia, annual barley production is ... Powdery mildew is one of the most important diseases of ... have discovered the composition of special growths on the cell ... fungus into the leaf. , The research, by the ARC ...
(Date:7/25/2014)... age girls reach puberty is influenced by ,imprinted genes,a subset ... the gene. This is the first evidence that imprinted ... details of this study were published today in the journal ... as menarche, is a marker for the timing of puberty ... menses varies between girls, is an inherited trait, and is ...
(Date:7/25/2014)... , July 25, 2014 ... consumers are turning to digital technology for online & ... NXTD), Google Inc. (NASDAQ: GOOG ), LifeLock ... V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused ...
Breaking Biology News(10 mins):New hope for powdery mildew resistant barley 2Could age of first period influence development of diseases in older women? 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6
... Plasmodium falciparum uses different pathways to invade ... complicating efforts to create effective vaccines against the disease. ... an international research scholar with the Howard Hughes Medical ... to switch back and forth between invasion pathways. ...
... process that has stumped scientists for many years: exactly ... cell's nucleus, where it has strong anti-carcinogenic effects. , ... door for future research on related compounds. The finding ... other diseases. , The research, which appears in a ...
... porphyria , Dana-Farber Cancer Institute researchers say they have ... irrational and demented behavior in porphyria, the disease believed ... ruler blamed for the loss of the American colonies ... symptoms of porphyria, a rare genetic blood disease which ...
Cached Biology News:Gene expands malaria's invasion options 2Gene expands malaria's invasion options 3Study shows how retinoic acid enters a cell's nucleus 2Study shows how retinoic acid enters a cell's nucleus 3Attacks of King George III's madness linked to key metabolism molecule 2Attacks of King George III's madness linked to key metabolism molecule 3
... the original Gene Pulser apparatus and accessory modules ... applied in the Gene Pulser II system, which ... the Gene Pulser II system has the dual ... widest range of settings to target specific cell ...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
... the submicron range are part of your ... control of particle size is important to ... reliably detect the component populations in your ... Size Analyzer uses Photon Correlation Spectroscopy (PCS) ...
...
Biology Products: